Results 251 to 260 of about 24,588 (279)

Omalizumab

Reactions Weekly, 2022
openaire   +2 more sources

The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab

Nature Communications, 2020
Pascal Gasser, Pascal Guntern, Theodore S Jardetzky   +2 more
exaly  

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Ioana Agache, Cezmi A Akdis, Mubeccel Akdis   +2 more
exaly  

Omalizumab

Reactions Weekly, 2015
openaire   +1 more source

Omalizumab

Reactions Weekly, 2013
openaire   +1 more source

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

Journal of Allergy and Clinical Immunology, 2013
Philippe Gevaert, Thibaut Van Zele, Peter Hellings   +2 more
exaly  

Omalizumab

Drugs of the Future, 2002
null Cullell-Young, M., null Bayes, M., null Leeson, P.A.   +2 more
openaire   +1 more source

Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma

American Journal of Respiratory and Critical Care Medicine, 2017
William Busse, Stanley J Szefler, Stephen J Teach   +2 more
exaly  

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange

Nature Communications, 2016
Luke F Pennington, Karthik Sathiyamoorthy, Kari Christine Nadeau   +2 more
exaly  

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Ioana Agache, Claudio A Rocha, Margarita Posso   +2 more
exaly